Raxibacumab
Kathryn Dzintars, Pharm.D., BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs
- Prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.